Tens of thousands of cholesterol medication bottles are being recalled nationwide due to manufacturing issues that could ...

By Gnaneshwar Rajan and Sriparna Roy Jan 30 (Reuters) - Regeneron Pharmaceuticals' executives voiced confidence in its ...

Details suggest two separate medications may present health risks.

Coverage of a new PCSK9 trial makes bold claims about prevention and risk reduction. But how well do they hold up to scrutiny—and what nuances do you need to know? Let’s dig in.

A new discovery may explain why so many people abandon cholesterol-lowering statins because of muscle pain and weakness. Researchers found that certain statins can latch onto a key muscle protein and ...

A new medication that combines an already approved drug with a new unapproved one has been shown to cut the level of LDL, or “bad” cholestero l, when statins aren’t helping enough. In the Phase 3 ...

Using a high-dose statin with ezetimibe significantly reduces levels of "bad" LDL cholesterol, increasing a person's chances of reaching healthy levels by 85%, researchers found. Adobe stock/HealthDay ...

B O S T O N, May 16 -- Under guidelines issued Tuesday by the National Institutes of Health, the number of people who can benefit from taking cholesterol-lowering statin drugs nearly triples. This is ...

Statins, long hailed for lowering cholesterol, might offer an unexpected benefit beyond heart health—they could help slow Alzheimer’s disease. A new study suggests that these common medications might ...

A drug originally developed to treat type 2 diabetes may protect the heart. Early research shows IC7Fc can lower cholesterol, ...

The Food and Drug Administration (FDA) warns that the popular cholesterol-lowering medications may cause memory loss and confusion, but long term use of the medications may reduce that risk. In a ...